
Club Med board approves Investindustrial offer
The board of Club Méditerranée (Club Med) has approved a bid made by Investindustrial to buy the firm, which could put an end to Ardian's attempt to take the company private.
Investindustrial's offer of €21 per share and €22.41 for the convertible bonds exceeds that made by Ardian and Fosun.
The offer is around 20% higher than existing offers on the table. It includes an additional €150m investment to boost growth.The GP plans to make a €15m capital investment in marketing, with a focus on digital; a €5m allocation to fund a new flagship store in Paris; a €5m injection to support a new advertising campaign; and a €2.5m commitment to modernise the company's loyalty programme. Around €61m would be directed towards the development of partnerships with global and local operators.
Investindustrial does not plan to distribute dividends for seven years. A debt-to-EBITDA ratio of 2.5x applies to the offer.
The battle for listed Club Med has been a long one. In May, Italian holding Edizione (controlled by the Benetton family) informed Ardian and Fosun it would not sell its Club Med shares as part of the take-private bid launched by the French private equity house and the Chinese conglomerate via the Gaillon Invest holding last year. The decision prompted Gaillon to threaten legal action.
Gaillon warned Edizione that its earlier decision to sell its 2% stake was final – in the absence of a rival takeover bid – and stated it might eventually resort to legal action to enforce the earlier agreement.
Gaillon reminded Edizione that the Italian holding had formally agreed to sell its shares and convertible bonds in a letter sent to the Club Med chairman on 26 June 2013.
Gaillon needed to secure a 50.1% stake in Club Med before being able to initiate a take-private. But Ardian and Fosun have suffered a series of setbacks since announcing plans to offer €17 per share to Club Med shareholders back in May last year. They later revised their bid to €17.5, an offer welcomed by the company's board at the end of June 2013 and which would have valued the company at around €557m.
However, two minority shareholder groups appealed the regulator's decision to authorise Club Med's takeover in July 2013. The ensuing legal battle halted the takeover process for several months. Earlier this month, Paris's appeal court rejected the minority shareholders' claims, effectively greenlighting Gaillon's take-private bid.
But earlier this year, it emerged that Strategic Holdings, an investment vehicle controlled by Andrea Bonomi's BI-Invest, had been building up a 6.5% stake in Club Med over the past two months, with a view to eventually control around 10% of the business.
Strategic Holdings has reportedly been building up its Club Med stake at the current share price of around €18.9; this is higher than the €17.5 per share offered by Gaillon as part of the takeover bid.
In a press release issued on 11 May, Gaillon stated the price paid by BI-Invest did not represent a realistic exit strategy for current shareholders since it only applies to a limited number of shares. Ardian and Fosun went as far as to threaten to take their takeover offer off the table and reconsider their positions in Club Med's shareholding, should "the behaviour of Strategic Holdings and a few speculative funds" prevent them from reaching the 50.1% threshold necessary for their take-private bid to be successful.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater